Population-Based Registry Analysis of Antidiabetics Dispensations: Trend Use in Spain between 2015 and 2018 with Reference to Driving
| Autor: | Francisco Herrera-Gómez, Paloma Criado-Espegel, Eduardo Gutiérrez-Abejón, F. Javier Álvarez |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
driving under the influence
Drugged driving - OECD countries Registry study Treatment duration Population Pharmaceutical Science insulins lcsh:Medicine lcsh:RS1-441 030209 endocrinology & metabolism Article Age and gender lcsh:Pharmacy and materia medica 03 medical and health sciences 0302 clinical medicine Medicamentos - Efectos fisiológicos antidiabetics Drug Discovery Insulin Medicine 030212 general & internal medicine Medical prescription education Driving under the influence education.field_of_study business.industry Diabetes celebrities lcsh:R Diabetes - Tratamiento Fitness to drive celebrities.reason_for_arrest diabetes mellitus Automoviles - Conducción 3209 Farmacología Molecular Medicine business Population-Based Registry Demography driving impairing medicines |
| Zdroj: | Pharmaceuticals, Vol 13, Iss 165, p 165 (2020) Pharmaceuticals Volume 13 Issue 8 |
| ISSN: | 1424-8247 |
| Popis: | Insulins and some oral antidiabetics are considered to be driving-impairing medicines (DIM) and they belong to the Driving under the Influence of Drugs, alcohol, and medicines (DRUID) category I (minor influence on fitness to drive). The trend of antidiabetics use in Castilla y Leó n from 2015 to 2018 is presented through a population-based registry study. Treatment duration with these medicines and the concomitant use of other DIMs were observed. An adjustment method was used with information from the drivers&rsquo license census. For all calculations, age and gender were taken into account. 3.98% of the general population used at least one antidiabetic, as well as 2.92% of drivers. The consumption of antidiabetics in men was higher than in women (4.35% vs. 3.61%, p = 0.001), and the use increases with age, especially from 35&ndash 39 years to 75&ndash 79 years in men and 85&ndash 89 years in women. Antidiabetics were consumed chronically, specifically 100% in the case of insulins and 95% in the case of oral antidiabetics. In addition to antidiabetics, 2.5 ± 1.86 DIMs were consumed, mainly anxiolytics (25.53%), opioids (23.03%), other analgesics and antipiretics (19.13%), and antidepressants (17.73%). Collaboration between pharmacists and physicians is a priority to clearly transmitting risks to patients. It is necessary that the health authorities include information on DIMs, such as the DRUID classification, in the prescription and dispensing software. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|